JPH0472547B2 - - Google Patents
Info
- Publication number
- JPH0472547B2 JPH0472547B2 JP59500679A JP50067984A JPH0472547B2 JP H0472547 B2 JPH0472547 B2 JP H0472547B2 JP 59500679 A JP59500679 A JP 59500679A JP 50067984 A JP50067984 A JP 50067984A JP H0472547 B2 JPH0472547 B2 JP H0472547B2
- Authority
- JP
- Japan
- Prior art keywords
- prosthesis
- vascular
- support member
- thread
- vein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000002792 vascular Effects 0.000 claims description 40
- 210000003462 vein Anatomy 0.000 claims description 31
- 210000001367 artery Anatomy 0.000 claims description 15
- 239000000463 material Substances 0.000 claims description 8
- 238000004804 winding Methods 0.000 claims description 4
- 241001494479 Pecora Species 0.000 claims description 3
- 238000009954 braiding Methods 0.000 claims description 3
- 229920002994 synthetic fiber Polymers 0.000 claims description 2
- 239000008280 blood Substances 0.000 description 15
- 210000004369 blood Anatomy 0.000 description 15
- 210000004204 blood vessel Anatomy 0.000 description 10
- 238000000034 method Methods 0.000 description 8
- 238000001631 haemodialysis Methods 0.000 description 4
- 230000000322 hemodialysis Effects 0.000 description 4
- -1 polyethylene terephthalate Polymers 0.000 description 4
- 241000283690 Bos taurus Species 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 241000282887 Suidae Species 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 206010062237 Renal impairment Diseases 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 238000004159 blood analysis Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 231100000857 poor renal function Toxicity 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/88—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements formed as helical or spiral coils
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
- A61M1/3653—Interfaces between patient blood circulation and extra-corporal blood circuit
- A61M1/3655—Arterio-venous shunts or fistulae
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Prostheses (AREA)
- External Artificial Organs (AREA)
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は、血管と血管との結合片またはバイパ
スとして使用する新規な血管補綴物に関し、特に
静脈と動脈間のバイパス等に使用する血管補綴物
に関するものである。Detailed Description of the Invention [Industrial Application Field] The present invention relates to a new vascular prosthesis used as a connecting piece between blood vessels or a bypass, and particularly to a vascular prosthesis used for a bypass between a vein and an artery. It is about things.
[従来の技術]
医療技術において、血管と血管の連結またはバ
イパスするための血管補綴物が、分析試験や血液
浄化のためのドレナージにおいて、比較的頻繁に
用いられている。この種のバイパスは、長期間に
わたつて体内に留置され、種々の目的で血液のド
レナージ部位として使用される。例えば、腎臓機
能に障害を有する患者に対して行われる、いわゆ
る血液透析、特に、毎週定期的に行われる人工腎
臓中における血液浄化等において、血管補綴物ま
たはバイパスを使用することが一般化している。BACKGROUND OF THE INVENTION In medical technology, vascular prostheses for connecting or bypassing blood vessels are used relatively often in analytical tests and drainage for blood purification. This type of bypass is left in the body for an extended period of time and is used as a drainage site for blood for various purposes. For example, the use of vascular prostheses or bypasses has become commonplace in so-called hemodialysis, which is performed on patients with impaired renal function, and in particular in blood purification in artificial kidneys, which is performed regularly every week. .
血管補綴物として、一般的には異種移植片
(heterograft)、即ち、牛、羊または豚から採取
された血管片が使用される。特別な方法で処理さ
れたこうした異種移植片は、クセノグラフト
(xenograft)と呼ばれ、長期間体内に留置する
ことを可能とするとともに組織和合性材料を構成
するために、動物から採取され、化学的または物
理的に処理された血管で構成される。こうしたバ
イパスは、外科手術によつて、一端が患者の腕の
動脈に結合され、他端が静脈に結合される。この
方法によつて、2本の血管が連結される。この状
態で、形成されたバイパスを通して、血液の断続
的なドレナージ、排出された血液の浄化及び浄化
された血液の血液循環系への復帰が行われる。 As vascular prostheses, generally used are heterografts, ie blood vessels taken from cows, sheep or pigs. These specially treated xenografts, called xenografts, are harvested from animals and treated with chemicals to allow them to remain in the body for long periods of time and to constitute tissue-compatible materials. Consists of physically or physically treated blood vessels. These bypasses are surgically connected at one end to an artery in the patient's arm and at the other end to a vein. This method connects two blood vessels. In this state, through the bypass formed, there is an intermittent drainage of blood, purification of the ejected blood and return of the purified blood to the blood circulation system.
[発明が解決しようとする課題]
しかしながら、動脈と静脈を結合するために、
従来の血管補綴物を使用した場合、以下に述べる
問題を生じる可能性があつた。[Problem to be solved by the invention] However, in order to connect arteries and veins,
When using conventional vascular prostheses, the following problems could occur.
血液のドレナージに関しては、皮膚の下に手術
によつて挿入されたバイパスには、カニユールが
刺通される。ドレナージを反復して行つた場合、
バイパスがその弾力性を失うこととなる。一方、
血液処理完了後にカニユーレを取り外す場合、血
液分析等において慣用的に行われているドレナー
ジにおいて採用されている方法と同様の方法によ
り、血液を凝固させるために、ドレナージ部位に
圧力を負荷することが必要となる。バイパスを構
成している血管補綴物が弾力を失つている場合、
バイパスに外部より圧力を負荷して血液を凝固さ
せた後に、バイパスまたは血管補綴物に対する圧
力が解除されると、バイパスまたは血管補綴物が
その弾性力の欠如により正常に拡開した状態に復
帰せず、圧縮状態のままとなり、血液の循環に惑
乱を生じるおそれがある。 For blood drainage, a bypass surgically inserted under the skin is pierced with a cannula. If drainage is repeated,
The bypass will lose its elasticity. on the other hand,
When removing the cannula after blood processing is completed, it is necessary to apply pressure to the drainage site in order to coagulate the blood, using a method similar to that used for drainage commonly used in blood analysis, etc. becomes. If the vascular prosthesis that makes up the bypass has lost its elasticity,
After external pressure is applied to the bypass to cause blood to coagulate, when the pressure on the bypass or vascular prosthesis is released, the bypass or vascular prosthesis may not return to its normal expanded state due to its lack of elasticity. Instead, it remains in a compressed state, which may disrupt blood circulation.
この主の血管補綴物を使用した場合におけるも
う一つの問題は、血管補綴物の一端が手術により
静脈等の血管に結合された場合に、このバイパス
より流出した血液により、バイパス部位付近の血
管に影響が与えられることである。実験によれ
ば、血管補綴物の接続部位から数センチメートル
の範囲において、静脈の狭窄が生じた。 Another problem when using this type of vascular prosthesis is that when one end of the vascular prosthesis is surgically connected to a blood vessel such as a vein, blood flowing out from the bypass may cause damage to the blood vessels near the bypass site. It is about being influenced. Experiments have shown that venous narrowing occurs within a few centimeters from the connection site of the vascular prosthesis.
そこで、本発明の目的は、上記の問題を解消す
ることが出来る血管補綴物を提供することにあ
る。 Therefore, an object of the present invention is to provide a vascular prosthesis that can solve the above problems.
[課題を解決するための手段]
本発明に関して、前記した従来法と比較して、
実質的な利点を持つ組織和合性材料の管状構成要
素からなる血管補綴物を提供することが可能であ
ることが判明した。本発明による血管補綴物は、
中空管状の補綴物本体内部に弾性復帰力を持つ支
持部材を備えており、この支持部材は、少なくと
も補綴物本体の一側端部より所定長突出して設け
られる。本発明を静脈への動脈の恒久的なまたは
長期にわたる接続に使用する場合、補綴物本体よ
り突出した支持部材は、静脈中に挿入された状態
で拡開して、静脈をその内側より拡開支持して、
静脈の狭窄を防止する。[Means for Solving the Problems] Regarding the present invention, compared to the conventional method described above,
It has been found that it is possible to provide a vascular prosthesis consisting of a tubular component of tissue compatible material that has substantial advantages. The vascular prosthesis according to the invention comprises:
A support member having an elastic return force is provided inside the hollow tubular prosthesis main body, and this support member is provided to protrude by a predetermined length from at least one side end of the prosthesis main body. When the present invention is used for a permanent or long-term connection of an artery to a vein, the support member protruding from the prosthesis body expands when inserted into the vein to expand the vein from the inside. support,
Prevents narrowing of veins.
補綴物本体は、組織和合性を有する天然または
合成材料によつて形成される。従つて、この補綴
物本体として、従来より周知の牛、羊または豚か
ら採取される異種移植片において使用される一般
的な材料を使用することが可能である。本発明に
よれば、補綴物本体は、異種移植片を化学的また
は物理的に特別に処理して調製されるクセノグラ
フと中に存在する物質によつて形成することが好
ましい。また、ポリエチレンテレフタレート、ポ
リテトラフルオロエチレン、ポリエチレン、ポリ
プロピレン等の合成樹脂製の組織和合製物質によ
り、補綴物を形成することも可能である。しかし
ながら、本発明においては、ヒト以外の異種移植
片タイプの生物学的物質を使用することが特に好
ましい。 The prosthesis body is formed from tissue-compatible natural or synthetic materials. It is therefore possible to use, as the body of the prosthesis, the conventional materials used in xenografts from cows, sheep or pigs, which are known in the art. According to the invention, the prosthesis body is preferably formed by a xenograph prepared by special chemical or physical treatment of the xenograft and the substances present therein. It is also possible to form a prosthesis with a tissue-integrated material made of synthetic resin such as polyethylene terephthalate, polytetrafluoroethylene, polyethylene, polypropylene, or the like. However, it is particularly preferred in the present invention to use biological materials of the non-human xenograft type.
中空管状の補綴物本体内に挿入される支持部材
は、種々の要領で設計することが出来る。例え
ば、この支持部材は、補綴物の内壁面に所定の拡
開圧力を付与する螺旋条渦巻バネとして構成する
ことが出来る。この場合、渦巻バネを形成する材
料としては、組織和合性のステンレス鋼または十
分な剛性を有するプラスチツク材料を用いること
が出来る。こうした渦巻バネの詳細は、例えばス
ウエーデン特許出願第8202740−0号に詳細に説
明されている。 The support member inserted into the hollow tubular prosthesis body can be designed in various ways. For example, the support member can be configured as a helical spiral spring that applies a predetermined expansion pressure to the inner wall surface of the prosthesis. In this case, the material for forming the spiral spring may be tissue compatible stainless steel or plastic material having sufficient rigidity. Details of such spiral springs are described in detail, for example, in Swedish Patent Application No. 8202740-0.
また、支持部材を、適度の剛性及び可撓性を持
つた糸条要素を組編して屈曲性を備え、補綴物本
体の中心軸線と共通の軸線を持つた管状体によつ
て構成することも可能である。この場合、管状体
を構成する各糸条要素は、一方向に巻回される1
乃至複数の糸状要素と逆方向に巻回される1乃至
複数の糸状要素で構成され、各糸状要素はスパイ
ラル状に巻回され、他の糸状要素に対して軸線方
向に所定長変位して配置され、他の糸状要素と交
差して組編構造を形成するものである。この組編
構造に形成された管状体は、軸線方向に伸縮性を
備え、伸張状態で縮径して、静脈への挿入を容易
とし、収縮状態で拡開して静脈内壁面に当接し
て、これを拡開支持するものである。 In addition, the support member may be constructed of a tubular body having flexibility by braiding yarn elements having appropriate rigidity and flexibility and having an axis common to the central axis of the prosthesis body. is also possible. In this case, each yarn element constituting the tubular body is wound in one direction.
Consisting of one or more thread-like elements wound in the opposite direction to the thread-like elements, each thread-like element is wound in a spiral and is disposed at a predetermined distance in the axial direction with respect to the other thread-like elements. The thread-like elements intersect with other thread-like elements to form a braided structure. The tubular body formed with this braided structure has elasticity in the axial direction, reduces its diameter in the stretched state to facilitate insertion into the vein, and expands in the contracted state to come into contact with the inner wall of the vein. , this will be expanded and supported.
血管補綴物の直径は、用途に応じて比較的広い
範囲で変化させることが出来るが、一般的には3
〜10mmの寸法である。補綴物本体の端部より突出
する支持部材の長さは、補綴物の内径の約20倍程
度までが適当であるが、所望の機能を得る上で
は、補綴物の内径の約3〜12倍が適当である。こ
の方法により、補綴物本体の端部より突出した部
分により、大気圧に対して負となる可能性のある
静脈等の血管を拡開支持して、その狭窄を未然に
防止することが出来るものとなる。 The diameter of the vascular prosthesis can vary within a relatively wide range depending on the application, but generally the diameter of the vascular prosthesis is 3.
The dimensions are ~10mm. The appropriate length of the support member protruding from the end of the prosthesis body is about 20 times the inner diameter of the prosthesis, but in order to obtain the desired function, it should be about 3 to 12 times the inner diameter of the prosthesis. is appropriate. With this method, the part protruding from the end of the prosthesis body can expand and support blood vessels such as veins that may be negative to atmospheric pressure, thereby preventing their narrowing. becomes.
本発明による血管補綴物を使用することによ
り、前述した従来技術における問題は、簡単に且
つ効果的に解消することが出来る。また、補綴物
本体内に収容された支持部材の部分の弾性復原力
によつて、血管補綴物は体内に留置された状態に
保持させる全期間にわたつて、十分な弾性を確保
することが可能となり、血液のドレナージを支障
なく行うことが出来るものとなる。また、反対方
向に巻回された渦巻バネを使用した場合には、血
管補綴物中にカニユーレを挿入したときに、バネ
材が拡開して、カニユーレを除去して支持部材が
縮径復元することにより、カニユーレの挿入によ
つて拡開された補綴物が収縮して、ほぼ自動的に
密閉状態とすることが出来る利点を得ることが出
来る。なお、この場合においても、支持部材の補
綴物本体から突出した部分を静脈内に挿入するこ
とにより、静脈の狭窄を防止することが出来るも
のである。 By using the vascular prosthesis according to the invention, the problems of the prior art mentioned above can be easily and effectively overcome. In addition, the elastic restoring force of the support member housed within the prosthesis body ensures sufficient elasticity for the entire period in which the vascular prosthesis is left in the body. Therefore, blood drainage can be performed without any hindrance. In addition, if a spiral spring wound in the opposite direction is used, when the cannula is inserted into the vascular prosthesis, the spring material expands, and the cannula is removed and the support member returns to its reduced diameter. This provides the advantage that the prosthesis, which has been expanded by insertion of the cannula, can be contracted and brought into a sealed state almost automatically. In this case as well, stenosis of the vein can be prevented by inserting the portion of the support member protruding from the prosthesis body into the vein.
[実施例]
添付図面は、本発明の実施例による血管補綴物
1の概略を示すもので、図示の例において血管補
綴物1は動脈5と静脈7に結合されて、静脈及び
動脈のバイパスを構成している。バイパスまたは
血管補綴物1は、支持部材として、螺旋状に巻回
された渦巻バネ3を有している。この渦巻バネ3
は、中空管状に形成された補綴物本体2の動脈側
接合端部9から、補綴物本体2内を挿通して静脈
側端部11に伸び、さらに、静脈側端部より所定
長突出した突出部13が静脈内に延長挿入されて
いる。[Embodiment] The accompanying drawings schematically show a vascular prosthesis 1 according to an embodiment of the invention, in the illustrated example the vascular prosthesis 1 is coupled to an artery 5 and a vein 7 to bypass the vein and artery. It consists of The bypass or vascular prosthesis 1 has a helically wound spiral spring 3 as a support element. This spiral spring 3
is a protrusion that extends from the arterial joint end 9 of the prosthesis main body 2 formed into a hollow tube shape, passes through the prosthesis main body 2 to the venous end 11, and further projects a predetermined length from the venous end. The portion 13 is extended and inserted into the vein.
補綴物本体2は、好ましくは、例えば牛より採
取され、適当な方法で化学的及び/または物理的
に処理された異種移植片で形成されたクセノグラ
フトにより構成する。渦巻バネ3は、医療上使用
が容認され得るステンレス鋼により構成される。 The prosthesis body 2 is preferably constituted by a xenograft formed of a xenograft taken from, for example, a cow and treated chemically and/or physically in an appropriate manner. The spiral spring 3 is made of stainless steel that is medically acceptable.
動脈5を静脈7に連結させるための血管補綴物
の使用及び挿入方法は、以下の通りである。 The method of use and insertion of the vascular prosthesis to connect the artery 5 to the vein 7 is as follows.
まず、第1段階として、患者の静脈を外科的手
術により切開し、次いでクセノグラフトで構成す
る補綴物本体2を、通常の方法により静脈の切開
箇所に結合刺せる。次いで支持部材を構成する渦
巻バネ3を、補綴物本体の外側より補綴物本体を
挿通して挿入する。この場合、渦巻バネ3を適当
な方法で回転させることによつて、縮径させた状
態で補綴物本体2内に挿入するとともに、図示の
ように突出部13を静脈内に挿入し、次いでこの
位置で渦巻バネ3に対する規制を解除してこれを
拡開させ、所定の圧力で補綴物本体2及び静脈7
の内壁面に当接させて、渦巻バネ3を補綴物本体
及び静脈に対して固定する。なお、静脈内に挿入
される突出部13の長さは、本発明の血管補綴物
を血液透析に使用する場合には、3〜4cmとする
ことが出来る。 First, as a first step, a patient's vein is surgically incised, and then a prosthesis body 2 made of a xenograft is attached to the incision site of the vein using a conventional method. Next, the spiral spring 3 constituting the support member is inserted through the prosthesis body from the outside of the prosthesis body. In this case, by rotating the spiral spring 3 in an appropriate manner, it is inserted into the prosthesis main body 2 in a reduced diameter state, and the protrusion 13 is inserted into the vein as shown in the figure. At this position, the restriction on the spiral spring 3 is released and it is expanded, and the prosthesis main body 2 and the vein 7 are opened with a predetermined pressure.
The spiral spring 3 is fixed to the prosthesis body and the vein by abutting against the inner wall surface of the prosthesis body and the vein. Note that the length of the protrusion 13 inserted into a vein can be 3 to 4 cm when the vascular prosthesis of the present invention is used for hemodialysis.
渦巻バネ3を補綴物本体2に挿入した後、バネ
3を補綴物本体の他端(動脈側端部)において切
断する。次いで、患者の皮膚を切開し、血管補綴
物を患者の皮膚下に挿入し、動脈5の切開された
開口に縫合により、補綴物本体の他端部を結合さ
せる。この例において、動脈内の血液は加圧状態
と成つているので、補綴物本体2の動脈側端部よ
り突出する渦巻バネの突出部を設けることは不要
である。 After the spiral spring 3 is inserted into the prosthesis body 2, the spring 3 is cut at the other end (the end on the artery side) of the prosthesis body. Next, the patient's skin is incised, the vascular prosthesis is inserted under the patient's skin, and the other end of the prosthesis body is joined to the incised opening of the artery 5 by suture. In this example, since the blood in the artery is under pressure, it is unnecessary to provide a protrusion of the spiral spring that protrudes from the artery side end of the prosthesis body 2.
血管補綴物の取り付けを完了すると、血管補綴
物は、容易に所定位置の保持することが出来、血
液のドレナージに際して容易に刺通することが出
来る。 Once the vascular prosthesis has been installed, it can be easily held in place and easily penetrated for blood drainage.
なお、上記の実施例において使用する渦巻バネ
3の詳細はスウエーデン特許出願第8202740−0
号に開示されている。 The details of the spiral spring 3 used in the above embodiments are given in Swedish patent application No. 8202740-0.
Disclosed in the issue.
支持部材の構成は、上記のものに限定されるも
のではなく、種々の構成を採用しうるもので、例
えば、支持部材を複数の糸状要素を組編みして構
成する管状体で構成することも可能である。この
管状体は、一方向の巻回方向を持つ1乃至複数の
糸状要素と、これと逆向きの巻回方向を持つ1乃
至複数の糸状要素をそれぞれ補綴物本体と共通の
軸線に関して、軸線方向に所定間隔変位させて配
設して、軸線方向に伸張された時に管状体が縮径
し、軸線方向に収縮された時に管状体の径が拡開
するように組編みして構成する。なお、管状体が
軸線方向に収縮した時に、径を拡開する方法は
種々考えられるが、好ましくは、管状体を伸張状
態に規制する規制力が解除されたときに、管状体
または管状体を構成する糸状要素の弾性復原力に
より、自動的に径が拡開復元する構成とする。こ
の弾性復元機能は、例えば糸状要素の張力を利用
して達成することが出来る。 The structure of the support member is not limited to the one described above, and various structures may be adopted. For example, the support member may be formed of a tubular body formed by braiding a plurality of thread-like elements. It is possible. This tubular body has one or more thread-like elements with one winding direction and one or more thread-like elements with the opposite winding direction, respectively, in the axial direction with respect to the common axis with the prosthesis body. The tubes are arranged at predetermined intervals and are braided so that the diameter of the tubular body decreases when it is expanded in the axial direction and expands when it is contracted in the axial direction. Although various methods can be considered for expanding the diameter of the tubular body when it contracts in the axial direction, it is preferable to expand the diameter of the tubular body when the restricting force that restricts the tubular body to the extended state is released. The diameter is automatically expanded and restored by the elastic restoring force of the thread-like elements. This elastic restoring function can be achieved, for example, by using the tension of the filamentous element.
なお、上記の管状体で構成した支持部材の機能
は、前述した螺旋バネにより構成した支持部材の
機能と同様である。 The function of the support member made of the tubular body described above is the same as that of the support member made of the helical spring described above.
本発明は、上記した実施例の構成に限定される
ものではなく、種々の変更、変形を包含するもの
であり、また本発明の用途も、試料の採取、分
析、透析等のための血液排出の目的で、バイパス
を形成することにより2つの血管を相互に連結す
ることを必要とするすべての用途に使用可能であ
る。さらに、血管補綴物の取付方法も、上記の方
法に限定されるものではなく、適宜の方法を採用
し得るものである。例えば、螺旋バネ等で構成す
る支持部材を予め補綴物本体に、突出部13を突
出した状態で挿入しておき、この状態で静脈及び
動脈に結合することも可能である。なお、この場
合、突出部を設けた側の端部が、突出部を静脈に
挿入した状態で静脈に縫合され、次いで他端が動
脈に結合されることとなる。 The present invention is not limited to the structure of the embodiments described above, but includes various changes and modifications, and the present invention is also applicable to blood discharge for sample collection, analysis, dialysis, etc. It can be used for all applications that require interconnecting two blood vessels by creating a bypass. Furthermore, the method for attaching the vascular prosthesis is not limited to the above method, and any appropriate method may be employed. For example, it is also possible to insert a support member made of a helical spring or the like into the prosthesis body in advance with the protrusion 13 protruding, and connect it to the vein and artery in this state. In this case, the end on the side where the protrusion is provided is sutured to the vein with the protrusion inserted into the vein, and then the other end is coupled to the artery.
上記のように、本発明によれば、上記した利点
に加えて、血管補綴物を例えば血液透析に使用す
るために皮下に取り付けた場合に、従来の血管補
綴物のように補綴物が折れ曲がつたり、回転する
ことがなく、常に一定の位置に保持することが出
来るものとなる。また、支持部材を内挿すること
により、血管補綴物には十分な弾性力が確保さ
れ、血管補綴物を操作上案全で、使用しやすいも
のとすることが出来る。 As mentioned above, according to the present invention, in addition to the above-mentioned advantages, when the vascular prosthesis is attached subcutaneously for use in hemodialysis, for example, the prosthesis does not bend like conventional vascular prostheses. It does not wobble or rotate and can always be held in a fixed position. In addition, by inserting the support member, sufficient elasticity is ensured in the vascular prosthesis, and the vascular prosthesis can be easily guided and used.
図は、定期的に血液透析を行うために長期間に
わたり体内に留置される本発明の実施例による血
管補綴物の概略を示す斜視図である。
1…血管補綴物、2…補綴物本体、3…螺旋バ
ネ、5…動脈、7…静脈、13…突出部。
The figure is a perspective view schematically showing a vascular prosthesis according to an embodiment of the present invention that is indwelled in the body for a long period of time for periodic hemodialysis. 1... Blood vessel prosthesis, 2... Prosthesis main body, 3... Helical spring, 5... Artery, 7... Vein, 13... Protrusion part.
Claims (1)
補綴物本体と、該補綴物本体内に挿入されるとと
もに、前記補綴物本体の少なくとも一側端部より
所定長突出し、該一側端部が結合される静脈中に
挿入される突出部を有する弾性復原力を備えた支
持部材で構成され、前記突出部を対応する端部が
結合される静脈に挿入した状態で動脈及び静脈間
を連結してバイパスを形成することを特徴とす
る、血管補綴物。 2 前記補綴物本体が牛、羊または豚より採取さ
れる異種移植片で構成される特許請求の範囲第1
項に記載した血管補綴物。 3 前記補綴物本体がクセノグラフトで構成され
る特許請求の範囲第1項に記載した血管補綴物。 4 前記補綴物本体が合成材料で形成される特許
請求の範囲第1項に記載の血管補綴物。 5 前記支持部材は、前記補綴物本体の内壁に所
定の圧力で当接して所定の拡開力を確保する螺旋
バネである特許請求の範囲第1〜4項のいずれか
に記載した血管補綴物。 6 前記支持部材は、複数の適度の剛性と可撓性
を備えた糸状要素によつて組編み形成された管状
体で構成され、該糸状要素は、一方向の巻回方向
に巻回された1乃至複数の第一の糸状要素と、第
一の糸状要素の巻回方向に巻回された1乃至複数
の糸状要素を軸線方向に所定間隔離間して相互に
交差するように配置して構成する特許請求の範囲
第1〜4項のいずれかに記載の血管補綴物。 7 前記突出部の補綴物本体端部からの突出長
は、補綴物本体の直径の約20倍、好ましくは3〜
12倍の長さである特許請求の範囲第1〜6項のい
ずれかに記載の血管補綴物。[Scope of Claims] 1. A tubular prosthesis body formed of a material having tissue affinity, which is inserted into the prosthesis body and protrudes by a predetermined length from at least one side end of the prosthesis body, The support member has an elastic restoring force and has a protrusion that is inserted into the vein to which the one end is connected, and the support member has an elastic restoring force and is inserted into the artery with the corresponding end inserted into the vein to which the corresponding end is connected. and a vascular prosthesis, characterized in that it connects veins to form a bypass. 2. Claim 1, wherein the prosthesis body is comprised of a xenograft taken from a cow, sheep, or pig.
Vascular prosthesis described in section. 3. The vascular prosthesis according to claim 1, wherein the prosthesis body is composed of a xenograft. 4. A vascular prosthesis according to claim 1, wherein the prosthesis body is formed of a synthetic material. 5. The vascular prosthesis according to any one of claims 1 to 4, wherein the support member is a helical spring that comes into contact with the inner wall of the prosthesis body with a predetermined pressure to ensure a predetermined expansion force. . 6. The support member is composed of a tubular body formed by braiding a plurality of thread-like elements having appropriate rigidity and flexibility, and the thread-like elements are wound in one winding direction. One or more first thread-like elements and one or more thread-like elements wound in the winding direction of the first thread-like element are arranged at a predetermined interval in the axial direction and intersect with each other. A vascular prosthesis according to any one of claims 1 to 4. 7 The protruding length of the protrusion from the end of the prosthesis body is about 20 times the diameter of the prosthesis body, preferably 3 to 3.
A vascular prosthesis according to any one of claims 1 to 6, which is 12 times as long.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8300578-5 | 1983-02-03 | ||
SE8300578A SE446372B (en) | 1983-02-03 | 1983-02-03 | BLOODKERL PROTES FOR USE AS SHUNT BETWEEN BLOODKERL |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS60500520A JPS60500520A (en) | 1985-04-18 |
JPH0472547B2 true JPH0472547B2 (en) | 1992-11-18 |
Family
ID=20349888
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP59500679A Granted JPS60500520A (en) | 1983-02-03 | 1984-01-26 | vascular prosthesis |
Country Status (5)
Country | Link |
---|---|
JP (1) | JPS60500520A (en) |
CH (1) | CH660299A5 (en) |
FR (1) | FR2540379A1 (en) |
SE (1) | SE446372B (en) |
WO (1) | WO1984003036A1 (en) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1202558B (en) * | 1987-02-17 | 1989-02-09 | Alberto Arpesani | INTERNAL PROSTHESIS FOR THE REPLACEMENT OF A PART OF THE HUMAN BODY PARTICULARLY IN THE VASCULAR OPERATIONS |
GB2203342B (en) * | 1987-04-07 | 1991-12-11 | Julian Garth Ellis | Radio-opaque tracer for surgical implants |
US5133732A (en) | 1987-10-19 | 1992-07-28 | Medtronic, Inc. | Intravascular stent |
DE4102550A1 (en) * | 1990-02-02 | 1991-08-08 | Stephan Prof Dr Bockenheimer | Sealing blood vessel fistula - involves inserted sleeve with spiral support with turns bridged by impervious elastic material |
FR2661603A1 (en) * | 1990-05-02 | 1991-11-08 | Coralines Abj Division Sarl | Prosthesis for treating stenoses in the channels of the body |
US5913900A (en) * | 1995-06-07 | 1999-06-22 | Corsscart, Inc. | Substantially native meniscal cartilage heterografts |
US5865849A (en) * | 1995-06-07 | 1999-02-02 | Crosscart, Inc. | Meniscal heterografts |
US6046379A (en) * | 1995-06-07 | 2000-04-04 | Stone; Kevin R. | Meniscal xenografts |
US5984858A (en) * | 1995-06-07 | 1999-11-16 | Crosscart, Inc. | Meniscal xenografts |
US6231608B1 (en) | 1995-06-07 | 2001-05-15 | Crosscart, Inc. | Aldehyde and glycosidase-treated soft and bone tissue xenografts |
US5902338A (en) * | 1995-09-15 | 1999-05-11 | Crosscart, Inc. | Anterior cruciate ligament heterograft |
US5944755A (en) * | 1995-09-15 | 1999-08-31 | Crosscart, Inc. | Articular cartilage xenografts |
US6049025A (en) * | 1995-09-15 | 2000-04-11 | Stone; Kevin R. | Articular cartilage xenografts |
US6110206A (en) * | 1995-09-15 | 2000-08-29 | Crosscart, Inc. | Anterior cruciate ligament xenografts |
US5782915A (en) * | 1995-09-15 | 1998-07-21 | Stone; Kevin R. | Articular cartilage heterografts |
US6210440B1 (en) | 1995-09-15 | 2001-04-03 | Kevin R. Stone | Anterior cruciate ligament xenografts |
US5747128A (en) * | 1996-01-29 | 1998-05-05 | W. L. Gore & Associates, Inc. | Radially supported polytetrafluoroethylene vascular graft |
US6019788A (en) * | 1996-11-08 | 2000-02-01 | Gore Enterprise Holdings, Inc. | Vascular shunt graft and junction for same |
US6102884A (en) | 1997-02-07 | 2000-08-15 | Squitieri; Rafael | Squitieri hemodialysis and vascular access systems |
US6488701B1 (en) | 1998-03-31 | 2002-12-03 | Medtronic Ave, Inc. | Stent-graft assembly with thin-walled graft component and method of manufacture |
EP1059891A4 (en) | 1998-03-06 | 2004-05-19 | Crosscart Inc | Soft tissue xenografts |
US6383732B1 (en) | 1999-02-11 | 2002-05-07 | Crosscart, Inc. | Method of preparing xenograft heart valves |
US6972041B1 (en) | 1998-03-16 | 2005-12-06 | Crosscart, Inc. | Bone xenografts |
CA2323866A1 (en) | 1998-03-16 | 1999-09-23 | Crosscart, Inc. | Bone xenografts |
US6099559A (en) * | 1998-05-28 | 2000-08-08 | Medtronic Ave, Inc. | Endoluminal support assembly with capped ends |
US6143022A (en) * | 1998-08-24 | 2000-11-07 | Medtronic Ave, Inc. | Stent-graft assembly with dual configuration graft component and method of manufacture |
US6267786B1 (en) | 1999-02-11 | 2001-07-31 | Crosscart, Inc. | Proteoglycan-reduced soft tissue xenografts |
US6730124B2 (en) | 2002-03-08 | 2004-05-04 | Musculoskeletal Transplant Foundation | Bone-tendon-bone assembly with cancellous allograft bone block |
US6890354B2 (en) | 2002-03-08 | 2005-05-10 | Musculoskeletal Transplant Foundation | Bone-tendon-bone assembly with allograft bone block and method for inserting same |
US7762977B2 (en) | 2003-10-08 | 2010-07-27 | Hemosphere, Inc. | Device and method for vascular access |
US7648524B2 (en) | 2005-12-23 | 2010-01-19 | Howmedica Osteonics Corp. | Porous tendon anchor |
US9375215B2 (en) | 2006-01-20 | 2016-06-28 | W. L. Gore & Associates, Inc. | Device for rapid repair of body conduits |
WO2008097905A1 (en) * | 2007-02-05 | 2008-08-14 | Boston Scientific Scimed, Inc. | Blood access apparatus and method |
US8906081B2 (en) | 2007-09-13 | 2014-12-09 | W. L. Gore & Associates, Inc. | Stented vascular graft |
US20110295181A1 (en) | 2008-03-05 | 2011-12-01 | Hemosphere, Inc. | Implantable and removable customizable body conduit |
US9463269B2 (en) | 2010-09-10 | 2016-10-11 | W. L. Gore & Associates, Inc. | Anastomotic devices and methods |
CN103813817A (en) | 2011-09-06 | 2014-05-21 | 海默斯菲尔有限公司 | Vascular access system with connector |
CA2927803C (en) | 2013-12-20 | 2021-12-28 | Cryolife, Inc. | Vascular access system with reinforcement member |
US10499920B2 (en) | 2016-11-10 | 2019-12-10 | Merit Medical Systems, Inc. | Anchor device for vascular anastomosis |
US11383072B2 (en) | 2017-01-12 | 2022-07-12 | Merit Medical Systems, Inc. | Methods and systems for selection and use of connectors between conduits |
EP3573682A4 (en) | 2017-01-25 | 2020-11-04 | Merit Medical Systems, Inc. | Methods and systems for facilitating laminar flow between conduits |
US11026704B2 (en) | 2017-03-06 | 2021-06-08 | Merit Medical Systems, Inc. | Vascular access assembly declotting systems and methods |
EP3600150B1 (en) | 2017-03-24 | 2023-05-17 | Merit Medical Systems, Inc. | Subcutaneous vascular assemblies for improving blood flow |
WO2019014444A2 (en) | 2017-07-14 | 2019-01-17 | Merit Medical Systems, Inc. | Releasable conduit connectors |
EP3655086A4 (en) | 2017-07-20 | 2021-04-07 | Merit Medical Systems, Inc. | Methods and systems for coupling conduits |
US11331458B2 (en) | 2017-10-31 | 2022-05-17 | Merit Medical Systems, Inc. | Subcutaneous vascular assemblies for improving blood flow and related devices and methods |
CN114126507A (en) * | 2019-07-17 | 2022-03-01 | 国立大学法人东北大学 | Blood vessel correction tool and method for supporting anastomotic part |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5443833A (en) * | 1977-09-14 | 1979-04-06 | Nippon Steel Corp | Method of casting steel ingot |
JPS5463588A (en) * | 1977-08-26 | 1979-05-22 | Sawyer Philip Nicholas | Heart and blood vessel prosthetics and method of fabricating same |
JPS57150954A (en) * | 1981-02-13 | 1982-09-17 | Thoratec Lab Corp | Artery implant prosthesis |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT261800B (en) * | 1966-08-22 | 1968-05-10 | Braun Internat Gmbh B | Process for the manufacture of tubular, smooth or threaded tissue-blood vessel prostheses |
CS148134B1 (en) * | 1970-11-20 | 1973-02-22 | ||
SE397769B (en) * | 1974-11-04 | 1977-11-21 | Gambro Ab | INITIATIVE ELEMENTS FOR USE IN VEHICLE SURGERY AND METHODS OF PRODUCING SUCCESSFUL |
GB1565828A (en) * | 1975-12-02 | 1980-04-23 | Plastiques Ind Soc | Implantable surgical pipeline |
US4130904A (en) * | 1977-06-06 | 1978-12-26 | Thermo Electron Corporation | Prosthetic blood conduit |
SE424401B (en) * | 1979-06-06 | 1982-07-19 | Bowald S | BLODKERLSPROTES |
US4300244A (en) * | 1979-09-19 | 1981-11-17 | Carbomedics, Inc. | Cardiovascular grafts |
-
1983
- 1983-02-03 SE SE8300578A patent/SE446372B/en not_active IP Right Cessation
-
1984
- 1984-01-26 WO PCT/SE1984/000025 patent/WO1984003036A1/en unknown
- 1984-01-26 JP JP59500679A patent/JPS60500520A/en active Granted
- 1984-01-26 CH CH5073/84A patent/CH660299A5/en not_active IP Right Cessation
- 1984-02-02 FR FR8401634A patent/FR2540379A1/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5463588A (en) * | 1977-08-26 | 1979-05-22 | Sawyer Philip Nicholas | Heart and blood vessel prosthetics and method of fabricating same |
JPS5443833A (en) * | 1977-09-14 | 1979-04-06 | Nippon Steel Corp | Method of casting steel ingot |
JPS57150954A (en) * | 1981-02-13 | 1982-09-17 | Thoratec Lab Corp | Artery implant prosthesis |
Also Published As
Publication number | Publication date |
---|---|
FR2540379A1 (en) | 1984-08-10 |
SE8300578D0 (en) | 1983-02-03 |
SE8300578L (en) | 1984-08-04 |
SE446372B (en) | 1986-09-08 |
JPS60500520A (en) | 1985-04-18 |
CH660299A5 (en) | 1987-04-15 |
WO1984003036A1 (en) | 1984-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH0472547B2 (en) | ||
US4665918A (en) | Prosthesis system and method | |
US5769821A (en) | Catheter tip retainer | |
CA2256458C (en) | Atraumatic anchoring and disengagement mechanism for permanent implant device | |
US5509900A (en) | Apparatus and method for retaining a catheter in a blood vessel in a fixed position | |
US4169477A (en) | Anastomatic couplings | |
EP3600150B1 (en) | Subcutaneous vascular assemblies for improving blood flow | |
EP2416733B1 (en) | Introducer assembly and implantable medical device | |
US5848964A (en) | Temporary inflatable filter device and method of use | |
US4512761A (en) | Body implantable connector | |
WO2018206160A1 (en) | A device for filtering embolic material in a vascular system | |
JP2018525206A (en) | Artificial vein valve | |
EP0183372A1 (en) | Prosthetic stent | |
US20130274648A1 (en) | Blood flow controllers and methods | |
ATE27541T1 (en) | EXPANDABLE FILTERS FOR BLOOD CLOTS. | |
CA2211516A1 (en) | Mechanical clot treatment device | |
NL8320142A (en) | PROSTHESIS COMPRISING OF AN EXPANDABLE OR STRETCHABLE TUBULAR BODY. | |
RU96114953A (en) | INTRA-VASCULAR IMPLANTABLE PROSTHETIS AND METHOD OF IMPLANTATION OF SUCH PROSTHESIS | |
US20090234431A1 (en) | Arteriovenous graft blood flow controllers and methods | |
US10682453B2 (en) | Vascular access system with reinforcement member | |
US20200306026A1 (en) | Filter device | |
JPH07124251A (en) | Blood filter for indwelling in artery | |
JP4067353B2 (en) | Intravascular blood filter | |
WO2007075515A2 (en) | Devices and methods to prevent bleeding from needle puncture sites of arteriovenous grafts | |
US9687240B2 (en) | Implant for facilitating sutureless side-to-side arteriovenous fistula creation and maintaining patency |